114
Participants
Start Date
August 1, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
intensive medical therapy
Dual antiplatelet therapy, high potency statins, HTN control, lifestyle modification
University of Rochester, Rochester
University of Maryland Medical Center, Baltimore
Emory University Hospital, Atlanta
University of Iowa, Iowa City
Northwestern Memorial Hospital, Chicago
Rush Medical Center, Chicago
Baylor Medicine, Houston
Hartford Hospital, Hartford
Baystate Medical Center, Springfield
University of Massachusetts Medical Center, Worcester
Rhode Island Hospital, Providence
Calgary Health Sciences Center, Calgary
University of Alberta, Edmonton
Vancouver General Hospital, Vancouver
University of Manitoba, Winnipeg
Northern Ontario School of Medicine, Greater Sudbury
Western University/London Health Sciences Center, London
CHUM, Montreal
University of Maryland, Baltimore
OTHER